![Western Blot: KIR3DS1/CD158e2 Antibody [NBP3-03813] - Analysis of extracts of various cell lines, using KIR3DS1/CD158e2 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.](http://images.novusbio.com/fullsize2/KIR3DS1-CD158e2 Antibody-Western Blot-NBP3-03813-img0003.jpg "Western Blot: KIR3DS1/CD158e2 Antibody [NBP3-03813] - Analysis of extracts of various cell lines, using KIR3DS1/CD158e2 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.")
| Reactivity | Hu, Mu, RtSpecies Glossary |
| Applications | WB, IHC, IHC-P |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 80-340 of human KIR3DS1/CD158e2 (NP_001077008.1). |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | KIR3DS1 |
| Purity | Affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
| Theoretical MW | 42 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
| Storage | Store at -20C. Avoid freeze-thaw cycles. |
| Buffer | PBS with 50% glycerol, pH7.3. |
| Preservative | 0.02% Sodium Azide |
| Purity | Affinity purified |
![ELISA: HLA B Antibody (2G7B10) [NBP2-61871] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/images2/HLA-B-Antibody-(2G7B10)-ELISA-NBP2-61871-img0001.jpg)
![Flow Cytometry: HLA B Antibody (2G7B10) [NBP2-61871] - Analysis of MCF-7 cells using HLA-B mouse mAb (green) and negative control (red).](http://images.novusbio.com/images2/HLA-B-Antibody-(2G7B10)-Flow-Cytometry-NBP2-61871-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: HLA B Antibody (2G7B10) [NBP2-61871] - Analysis of Hela cells using HLA-B mouse mAb. Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/images2/HLA-B-Antibody-(2G7B10)-Immunocytochemistry-Immunofluorescence-NBP2-61871-img0003.jpg)
![Western Blot: KIR2DS3 Overexpression Lysate (Adult Normal) [NBL1-12303] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for KIR2DS3.](http://images.novusbio.com/images/KIR2DS3 Overexpression Lysate (Adult Normal)-Western Blot-NBL1-12303-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: KIR2DS2 Antibody [NBP2-15005] - Analysis of methanol-fixed A431, using antibody at 1:500 dilution.](http://images.novusbio.com/images2/KIR2DS2 Antibody-Immunocytochemistry-Immunofluorescence-NBP2-15005-img0001.jpg)
![Immunohistochemistry-Paraffin: KIR2DS2 Antibody [NBP2-15005] - Paraffin-embedded Hepatoma, using antibody at 1:500 dilution.](http://images.novusbio.com/images2/KIR2DS2 Antibody-Immunohistochemistry-Paraffin-NBP2-15005-img0002.jpg)
![Western Blot: KIR2DS2 Antibody [NBP2-15005] - Sample (30 ug of whole cell lysate) A: Jurkat 10% SDS PAGE; antibody diluted at 1:1000.](http://images.novusbio.com/images2/KIR2DS2 Antibody-Western Blot-NBP2-15005-img0003.jpg)
![Western Blot: KIR3DP1 Overexpression Lysate (Adult Normal) [NBP2-08750] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for KIR3DP1.](http://images.novusbio.com/images/KIR3DP1 Overexpression Lysate (Adult Normal)-Western Blot-NBP2-08750-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: Rpn2 Antibody [NBP2-38323] - Immunofluorescent staining of human cell line U-2 OS shows localization to nucleoplasm & actin filaments.](http://images.novusbio.com/images2/Rpn2-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-38323-img0004.jpg)
![Immunohistochemistry-Paraffin: Rpn2 Antibody [NBP2-38323] - Staining of human cerebral cortex, kidney, liver and testis using Anti-PSMD1 antibody NBP2-38323 (A) shows similar protein distribution across tissues to independent antibody NBP2-38324 (B).](http://images.novusbio.com/images2/Rpn2-Antibody-Immunohistochemistry-Paraffin-NBP2-38323-img0005.jpg)
![Immunohistochemistry-Paraffin: Rpn2 Antibody [NBP2-38323] - Staining of human testis.](http://images.novusbio.com/images2/Rpn2-Antibody-Immunohistochemistry-Paraffin-NBP2-38323-img0006.jpg)
Secondary Antibodies |
Isotype Controls |
Diseases for KIR3DS1/CD158e2 Antibody (NBP3-03813)Discover more about diseases related to KIR3DS1/CD158e2 Antibody (NBP3-03813).
| Pathways for KIR3DS1/CD158e2 Antibody (NBP3-03813)View related products by pathway.
|
PTMs for KIR3DS1/CD158e2 Antibody (NBP3-03813)Learn more about PTMs related to KIR3DS1/CD158e2 Antibody (NBP3-03813).
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
| Gene Symbol | KIR3DS1 |
![Immunohistochemistry-Paraffin: KIR3DS1/CD158e2 Antibody [NBP3-03813] - Paraffin-embedded human mammary cancer using KIR3DS1/CD158e2 antibody at dilution of 1:100 (40x lens).](http://images.novusbio.com/fullsize2/KIR3DS1-CD158e2-Antibody-Immunohistochemistry-Paraffin-NBP3-03813-img0002.jpg "Immunohistochemistry-Paraffin: KIR3DS1/CD158e2 Antibody [NBP3-03813] - Paraffin-embedded human mammary cancer using KIR3DS1/CD158e2 antibody at dilution of 1:100 (40x lens).")
![Immunohistochemistry-Paraffin: KIR3DS1/CD158e2 Antibody [NBP3-03813] - Paraffin-embedded human liver using KIR3DS1/CD158e2 antibody at dilution of 1:100 (40x lens).](http://images.novusbio.com/fullsize2/KIR3DS1-CD158e2-Antibody-Immunohistochemistry-Paraffin-NBP3-03813-img0001.jpg "Immunohistochemistry-Paraffin: KIR3DS1/CD158e2 Antibody [NBP3-03813] - Paraffin-embedded human liver using KIR3DS1/CD158e2 antibody at dilution of 1:100 (40x lens).")
![KIR3DL1 Antibody (DX9) [Unconjugated]](/sites/all/modules/enterprise-tech/et_datasheets/images/novus_guarantee.png "KIR3DL1 Antibody (DX9) [Unconjugated]")
![Immunohistochemistry-Paraffin: GEM Antibody [NBP1-58906] - Human Skin Cellular Data: Squamous epithelial tissue section. Magnification: 400X.](http://images.novusbio.com/images2/GEM-Antibody-Immunohistochemistry-Paraffin-NBP1-58906-img0007.jpg)
![Immunohistochemistry: GEM Antibody [NBP1-58906] - Human kidney tissue section. Magnification: 400X.](http://images.novusbio.com/images2/GEM-Antibody-Immunohistochemistry-NBP1-58906-img0008.jpg)
![Western Blot: GEM Antibody [NBP1-58906] - Human Stomach Tumor cell lysate. Antibody at 1.0 ug/mL.](http://images.novusbio.com/images2/GEM-Antibody-Western-Blot-NBP1-58906-img0009.jpg)
![Immunohistochemistry-Paraffin: TRAILR2/TNFRSF10B Antibody [NB100-56618] - TRAIL R2/TNFRSF10B Antibody [NB100-56618] - Analysis of a formalin fixed paraffin-embedded (FFPE) human brain cerebellum using 1:200 conc. of TRAIL R2/TNFRSF10B antibody on a Bond Rx autostainer (Leica Biosystems). The assay involved 30 minutes of heat induced antigen retrieval (HIER) using 10mM sodium citrate buffer (pH 9.0) and endogenous peroxidase quenching with peroxide block. The sections were incubated with primary antibody for 15 minutes and Bond Polymer Refine Detection (Leica Biosystems) with DAB was used for signal development followed by counterstaining with hematoxylin. Cytoplasmic staining was observed in the Purkinje cell layer.](http://images.novusbio.com/images2/TRAIL-R2-TNFRSF10B-Antibody-Immunohistochemistry-Paraffin-NB100-56618-img0007.jpg)
![Immunohistochemistry: TRAILR2/TNFRSF10B Antibody [NB100-56618] - Pharmacodynamic assays for ONC201. IHC analyses of CHOP, TRAILR2/TNFRSF10B, and double-stranded DNA breaks (TUNEL) in baseline and ONC201-treated biopsies for an endometrial cancer patient. The biopsy was done 9.8 months after starting ONC201 treatment (7 days after the most recent ONC201 dose). Image collected and cropped by CiteAb from the following publication (https://jitc.biomedcentral.com/articles/10.1186/s40425-019-0599-8) licensed under a CC-BY licence.](http://images.novusbio.com/images2/TRAILR2-TNFRSF10B-Antibody-Immunohistochemistry-NB100-56618-img0008.jpg)
![Western Blot: TRAILR2/TNFRSF10B Antibody [NB100-56618] - TRAIL R2/TNFRSF10B Antibody [NB100-56618] - Analysis using the Azide Free version of NB100-56618. Detection of 20 ug of whole cell lysates from HL60 cells with anti-TRAIL-R2 at 5 ug/ml.](http://images.novusbio.com/images2/TRAIL-R2-TNFRSF10B-Antibody-Western-Blot-NB100-56618-img0003.jpg)
